Funzela Indications/Uses

For the treatment of the following infections caused by susceptible strains of microorganisms: Crytococcosis including cryptococcal meningitis and infections at other sites.
Systemic candidiasis, including candidemia, disseminated candidiasis and other forms of invasive candidal infection including infections of the peritoneum, endocardium, eye, respiratory and urinary tracts.
Mucosal candidiasis including oropharyngeal, esophageal, non-invasive bronchopulmonary infections, candiduria, mucocutaneous and denture sore mouth.
Genital candidiasis including vaginal candidiasis (acute or reccurrent), candidal balanitis.
Deep endemic mycoses, including coccidiomycosis, paracoccidiomycosis, blastomycosis, sporotrichosis and histoplasmosis in immunocompetent patients.
Superficial fungal infections such as dermatomycosis and onychomycosis including tinea pedis, tinea capitis, tinea corporis, tinea cruris, tinea versicolor, and dermal candida infections.
For the prophylaxis of transplant patients, patients with malignancy who are receiving cytotoxic chemotherapy, immunosuppressive therapy or radiation therapy, and other patients who are at risk of developing candida infections and serious fungal infections such as coccidioidomycosis and cryptococcal infections.
For the prophylaxis of HIV/AIDS patients who are at risk of developing candida infections and serious fungal infections such as coccidioidomycosis and cryptococcal infections.